Abstract
The synthetic peptide octarphin (TPLVTLFK, fragment 12–19 of β-endorphin), a selective agonist of nonopioid β-endorphin receptor, was prepared with specific activity 28 Ci/mmol. The binding of [3H]octarphin to T and B lymphocytes isolated from the blood of donors was studied. It was found that [3H]octarphin binds both to T and B cells with high affinity: K d = 3.0 ± 0.2 and 3.2 ± 0.3 nM, respectively. The specific binding of [3H]octarphin to T and B lymphocytes was competitively inhibited by unlabeled β-endorphin (K i = 1.9 ± 0.2 and 2.2 ± 0.3 nM, respectively) and was not inhibited by unlabeled naloxone, [Met5]enkephalin, [Leu5]enkephalin, α-endorphin, and γ-endorphin. Thus, T and B lymphocytes of human blood possess a nonopioid β-endorphin receptor whose binding is provided by the fragment 12–19 (the octarphin sequence).
Similar content being viewed by others
Abbreviations
- Con A:
-
concanavalin A
- HSCIE:
-
high-temperature solid-state catalytic isotope exchange
- [IC]50 :
-
concentration of inhibitor that causes 50% inhibition
- K d :
-
equilibrium dissociation constant
- K i :
-
equilibrium inhibition constant
- SEM:
-
the variation coefficient of the standard error of estimated mean
References
Navolotskaya, E. V., Kovalitskaya, Y. A., Zolotarev, Y. A., and Sadovnikov, V. B. (2008) J. Peptide Sci., 14, 1121–1128.
Kovalitskaya, Yu. A., Sadovnikov, V. B., Kolobov, A. A., Zolotarev, Yu. A., Yurovskii, V. V., Lipkin, V. M., and Navolotskaya, E. V. (2008) Bioorg. Khim., 34, 36–42.
Nekrasova, Yu. N., and Navolotskaya, E. V. (2012) Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology, 6, 82–91.
Kovalitskaya, Yu. A., Nekrasova, Yu. N., Sadovnikov, V. B., Zolotarev, Yu. A., and Navolotskaya, E. V. (2011) Biochemistry (Moscow), 76, 596–604.
Nekrasova, Y. N., Sadovnikov, V. B., Zolotarev, Y. A., and Navolotskaya, E. V. (2010) J. Peptide Sci., 16, 263–268.
Nekrasova, Yu. N., Zolotarev, Yu. A., and Navolotskaya, E. V. (2011) Biochemistry (Moscow), 76, 1337–1341.
Nekrasova, Y. N., Zolotarev, Y. A., and Navolotskaya, E. V. (2012) J. Peptide Sci., 18, 83–87.
Nekrasova, Y. N., Zolotarev, Y. A., and Navolotskaya, E. V. (2012) J. Peptide Sci., 18, 495–499.
Schnolzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S. B. H. (1992) Int. J. Peptide Protein Res., 40, 180–193.
Zolotarev, Yu. A., Dadayan, A. K., Bocharov, E. V., Borisov, Yu. A., Vaskovsky, B. V., Dorokhova, E. M., and Myasoedov, N. F. (2003) Amino Acids, 24, 325–333.
Boyum, A., Berg, T., and Blomhoff, R. (1983) in Iodinated Density Gradient Media — A Practical Approach (Rickwood, D., ed.) Oxford, pp. 147–170.
Patel, D., Rubbi, C. P., and Rickwood, D. (1995) Clin. Chim. Acta, 240, 187–193.
Pennock, B. E. (1973) Anal. Biochem., 56, 306–309.
Chang, Y. C., and Prusoff, W. H. (1973) Biochem. Pharmacol., 22, 3099–3108.
Gilman, S. C., Schwartz, J. M., Milner, R. J., Bloom, F. E., and Feldman, J. D. (1982) Proc. Natl. Acad. Sci. USA, 79, 4226–4230.
Gilmore, W., and Weiner, L. P. (1989) Immunopharmacology, 17, 19–30.
Kusnecov, A. W., Husband, A. J., Pang, G., and Smith, R. (1987) Brain Behav. Immun., 1, 88–97.
Van Den Bergh, P., Rozing, J., and Nagelkerken, L. (1991) Immunology, 72, 537–543.
Navolotskaya, E. V., Malkova, N. V., Zargarova, T. A., Lepikhova, T. N., Zav’yalov, V. P., and Lipkin, V. M. (2001) Peptides, 22, 2009–2013.
Navolotskaya, E. V., Malkova, N. V., Zargarova, T. A., Lepikhova, T. N., Krasnova, S. B., and Lipkin, V. M. (2002) Biochemistry (Moscow), 67, 357–363.
Sharp, B. M. (2006) Brain Behav. Immun., 20, 9–14.
Hazum, E., Chang, K. J., and Cuatrecasas, P. (1979) Science, 205, 1033–1035.
Navolotskaya, E. V., Kovalitskaya, Y. A., Zolotarev, Y. A., Kolobov, A. A., Kampe-Nemm, E. A., Malkova, N. V., Yurovsky, V. V., and Lipkin, V. M. (2004) Biochemistry (Moscow), 69, 394–400.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2013, Vol. 78, No. 3, pp. 407–412.
Rights and permissions
About this article
Cite this article
Nekrasova, Y.N., Zolotarev, Y.A. & Navolotskaya, E.V. Interaction of synthetic peptide octarphin with human blood lymphocytes. Biochemistry Moscow 78, 309–313 (2013). https://doi.org/10.1134/S0006297913030140
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297913030140